News
Pharmageddon,' a documentary directed by Donal O'Neill and produced by cardiologist Aseem Malhotra, was launched recently at ...
Pharmaceutical manufacturers, such as Pfizer, Johnson & Johnson, and Novartis, are driving digital transformation to enhance production efficiency and maintain compliance—an essential factor in ...
Rocket Pharmaceuticals (RCKT) stock is collapsing after the US Food and Drug Administration (FDA) paused the company's gene therapy trial following the death of a patient. Piper Sandler analysts ...
Pharmaceutical manufacturing encompasses all processes involved in the manufacturing and production of biological and medical products, botanical drugs, and herbs, as well as other pharmaceutical ...
Find the latest high-quality Pixel 10 wallpapers in this post. To download the complete list of all Google Pixel 10 wallpapers, including both light and dark versions, you can download this full ...
Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) fell short of the market’s revenue expectations in Q1 CY2025, with sales flat year on year at $897.8 million. On the other hand, the company ...
He said he expects the order will reduce the cost of pharmaceuticals by 30% to 80%. "Our Country will finally be treated fairly, and our citizens [sic] Healthcare Costs will be reduced by numbers ...
Throughout the last three months, 12 analysts have evaluated Rhythm Pharmaceuticals RYTM, offering a diverse set of opinions from bullish to bearish. The table below offers a condensed view of ...
Twenty years ago, the American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable (ACS GCIPR) launched with the goal of discussing common issues and learning from each member ...
JERUSALEM, May 7 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab reported a larger than expected rise in first-quarter profit, helped by strong sales gains for a trio of its ...
The expansion announcements come at a time when President Donald Trump has threatened massive tariffs on pharmaceutical imports to the U.S. Others say it's not certain if these plans — by ...
The company unveiled its first-quarter results. Unfortunately, it missed analyst estimates on both the top and bottom lines. In its first quarter, Apellis booked revenue of $166.8 million, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results